Cargando…
MicroRNAs in Myeloid Hematological Malignancies
MicroRNAs are 19-24 nucleotides noncoding RNAs which silence modulate the expression of target genes by binding to the messenger RNAs. Myeloid malignancies include a broad spectrum of acute and chronic disorders originating from from the clonal transformation of a hematopoietic stem cell. Specific g...
Autores principales: | Ciccone, Maria, Calin, George Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763972/ https://www.ncbi.nlm.nih.gov/pubmed/27047254 http://dx.doi.org/10.2174/138920291605150710122815 |
Ejemplares similares
-
MicroRNAs in Autoimmunity and Hematological Malignancies
por: Marco, Mirco Di, et al.
Publicado: (2018) -
From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
por: Ciccone, Maria, et al.
Publicado: (2015) -
Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
por: Gaál, Zsuzsanna
Publicado: (2022) -
Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation
por: Sevcikova, Aneta, et al.
Publicado: (2023) -
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies
por: El-Daly, Sherien M., et al.
Publicado: (2020)